Navigation Links
Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
Date:8/20/2007

... with Sales Team Forming and Increased Space, Poised for Market Launch

KIRKLAND, Wash., Aug. 20 /PRNewswire/ -- Pathway Medical Technologies, Inc., which is developing innovative devices for the treatment of arterial disease, today announced that it has hired a VP of Sales, Joseph W. Rafferty, and has started building its sales team in preparation for the introduction of its first product, Pathway PV(TM) Atherectomy System.

Recently Pathway moved from its old 10,000-square-foot facility to a new state-of-the art 51,000-square-foot, cGMP (Good Manufacturing Practices) - compliant manufacturing facility at 10801 120th Ave NE in Kirkland. The new facility boasts a 6,500-square-foot clean room to meet anticipated market demand. Additional 3000-square-feet are available for future expansion purposes. In the last six months the company's staff has grown from 53 to 91, almost doubling the size of the company, and Pathway continues to add employees to prepare for its first product introduction.

Mr. Rafferty, who will be working out of the company's new headquarters, joins the Pathway executive team with more than 25 years of experience in the medical-device industry. He has held senior sales and marketing management positions at companies like ACS/Guidant, where his contributions led to its leadership position in interventional cardiology. In his role as the Midwest Region Sales Manager, he pioneered Guidant's highly successful P3 (price-per- procedure) program, which ultimately redefined the reimbursement model for interventional cardiology.

"Joe brings extensive field sales, sales management and operational management experience to our team. He will be a significant contributor to the success of Pathway's premier new product. He knows how to build a leading sales organization for a category leader," said Pathway CEO and President Tom Clement.

"When you have a product about to launch with all the hallmarks of a category leader, it's ex
'/>"/>

SOURCE Pathway Medical Technologies, Inc.

Copyright©2007 PR Newswire.

Page: 1 2

Related biology technology :

1. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
2. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
3. In Vivo Signal Transduction Pathway Reporting Systems
4. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
5. New Fusion Trans-Activator Plasmids for Studying Signal Transduction Pathways
6. Medical College receives $377K to study brain disease
7. Barriers will not stop convergence of medical technologies
8. Medical College team creates website for tracking flu
9. Biomedical engineering conference invites manufacturers
10. Visions: Wade offers straight talk on e-medical records
11. Merge unveils updated medical imaging software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  AsureQuality and Ubiquitome have agreed to collaborate ... food and primary production sectors. The collaboration will ... the Freedom4. AsureQuality provides quality assurance ... shelf for producers, processors and Competent Authorities around ... control and pest management and surveillance programmes. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... solutions, today announced its GHS Label Guide . To align chemical container ... (GHS), this guide includes explanations of label components, an example of an accurate ...
(Date:7/29/2015)... -- Pfenex Inc. (NYSE MKT: PFNX) announced today that its ... Thursday, August 13, 2015, before the open of market.  ... a conference call to discuss the financial results and ... financial results and business update will be publicly distributed ... (US) or 1-412-542-4131 (international) and reference Pfenex to access ...
(Date:7/29/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... pleased to announce that the final design specifications ... locked.  Prototypes for industrial and regulatory testing will ... for CE mark clearance to market the injector ... (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  ...
Breaking Biology Technology:AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Brady Announces a New GHS Label Guide 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5
... 28 , - New ... , Bial-Portela & CA, S.A., ... Portela), and Eisai Europe Limited (London; Chairman & CEO ... President &,CEO: Haruo Naito), today announced that the novel ...
... scientists have unlocked the physics of the perfect pizza ... generation of micro motors thinner that a human hair. ... by Associate Professor James Friend and Senior Lecturer Leslie ... team from Monash,s Micro/Nanophysics Research Laboratory, then calculated how ...
... -- Encorium Group, Inc. (Nasdaq: ... (CRO) that provides design, development, and management capabilities ... of the world,s leading pharmaceutical companies, today announced ... Annual Vaccine Industry Excellence Award for Best Contract ...
Cached Biology Technology:Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 2Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 3Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 4Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 5Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 6Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 7Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 8Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 9Pizza tossing art unlocks secrets of tiny motors 2Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 2Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 3Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 4
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
(Date:7/7/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a biometric ... revised version of one of its first 30 second commercials will ... New York , Chicago , ... metro areas.    , , , , ... the cards in your wallet and keep your identity secure. ...
(Date:6/30/2015)... HATFIELD, Pa. , June 30, 2015 ... joined the company as CEO to help further develop ... a wealth of partnering experience, having spent much of ... companies including Therakine, Amgen, Baxter Bioscience, and Johnson & ... a focus on Technology and Biotech Corporate Finance. He ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... established HPV types. Cancerous human papillomavirus (HPV) viruses are the ... to 100% of cervical tumors. Cervical cancer and ... virus using standard techniques can sometimes give a negative result ... In a new study published in Virology , ...
... critically endangered large primate known as the drill ( ... few critical habitat areas in Cameroon, according to a ... Zoo,s Institute for Conservation Research. The study highlights ... area becomes ever more fragmented by human disturbance. ...
... infectious diseases meeting of the American Society for Microbiology ... Antimicrobial Agents and Chemotherapy (ICAAC) will be held September ... Colorado. Known as the preeminent world meeting for ... infectious diseases and anti-infective therapy, ICAAC has also traditionally ...
Cached Biology News:53rd ICAAC: Media registration now open 2
... for RNA aptamer screening and binding optimization ... Paraflo microfluidic on-chip synthesis platform. These microarrays ... DNA/RNA Aptamer Microarray Service. Probe ... Microarray contains greater than 1500 known aptamer ...
... RNA aptamer screening and binding optimization and ... microfluidic on-chip synthesis platform. Thousands of customer ... and LC Sciences can provide assistance with ... as part of our comprehensive DNA/RNA Aptamer ...
... (GST) is commonly used as a fusion ... (1). The GSTTag sequence has been reported ... cases the solubility of its fusion partners. ... form, GSTTag fusion proteins can be purified ...
... from the C-terminal end of the mouse retinoic acid receptor beta (RAR*). ... 448 of RAR*. The sequence of PEP-005 is (amino to carboxy ... - S - S - V - E - N - S ... - L - L - Q (The N-terminal cysteine has been ...
Biology Products: